Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EACR 2012 /
Epithelial mesenchyme transition in cancer cells

7th - 10th Jul 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.07.12
Views: 4810

Prof Jean-Paul Thiery – Institute of Molecular and Cell Biology, Singapore

Prof Jean-Paul Thiery discusses the reversible transition of tumour cells from an epithelial to a mesenchyme state and explains the potential role that targeting this transition could play in cancer therapy. The epithelial mesenchyme transition is necessary for tumours to successfully metastasise, and following new research recording the development of cancer cells it is now known that this occurs at a very early stage in cancer development. Mesenchyme-like cells have a very high chemo-resistance and consequently Prof Thiery’s research establishes the need for cancer therapies designed to restore cell chemo-sensitivity.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation